Quick Answer
FibroBiologics, Inc. reported Total Assets of $9.62 million for fiscal year 2025.
FibroBiologics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $9.62M | -41.5% |
| 2024 | $16.45M | +39.1% |
| 2023 | $11.82M | +145.0% |
| 2022 | $4.82M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $8.74M | -16.5% | -37.1% |
| June 30, 2025 | $13.91M | +56.0% | +21.7% |
| March 31, 2025 | $11.43M | +0.2% | -30.5% |
| December 31, 2024 | $16.45M | +39.1% | +57.1% |
| September 30, 2024 | $10.47M | — | +17.5% |
| June 30, 2024 | $8.91M | — | -21.8% |
| March 31, 2024 | $11.40M | — | -3.6% |
| December 31, 2023 | $11.82M | — | — |
- FibroBiologics, Inc. showed a decrease of -41.5% in Total Assets compared to the prior fiscal year.
- Over the 2022–2025 period, FibroBiologics, Inc.’s total assets has grown by 99.4% (from $4.82 million to $9.62 million).
- The most recent figure is from FibroBiologics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: